Octapharma is a privately-owned global human protein manufacturer. The company improves patients’ lives with products derived from human plasma and human cell lines. Currently, Octapharma is investing EUR 65 millions in the construction of a new Research center with laboratories and offices as well as a new production line for pilot production in Vienna. The company employs almost 1,200 highly skilled employees in Austria.
Oberlaaer Str. 235
1100 Vienna
Vienna
Contact:
Telephone: +43 (1) 61032-1313
Email: office@octapharma.at
Website